Persistent inflammation and immunosuppression after pediatric surgery: an exploratory observational study
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2026.227802Keywords:
Cytokines, Immunosuppression, Inflammation, Myeloid-derived suppressor Cells, Pediatric surgeryAbstract
Introduction: Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS) has recently become a focus of research in the pediatric population (pPICS). However, significant debate exists regarding its prevalence and optimal diagnostic criteria. Although the PICS pathophysiology in critically ill adults and children may be similar, no studies have evaluated the involvement of myeloid-derived suppressor cells (MDSCs) in pPICS. Aim. This exploratory study aimed to evaluate the
incidence of pPICS biomarkers of inflammation and immunosuppression in a small cohort of pediatric surgical patients and to explore these biomarkers’ associations with preoperative MDSCs, cytokine levels, and postoperative outcomes. Methods: Children and adolescents under 19 years undergoing elective or emergency surgery at a public tertiary-care university hospital were eligible, excluding those with chronic inflammatory diseases or immunosuppression. Preoperative blood samples were collected for phenotyping inflammatory monocytes, granulocytic and monocytic MDSCs, CD4+ and CD8+ T cells, and programmed cell death protein 1 (PD1) expression on T cells. TNF-α, IFN-γ, and IL- 10 plasma levels were also measured. Following surgery, patients were monitored weekly for pPICS biomarkers, defined by serum C-reactive protein >1.0 mg/dL, lymphocyte count <800 cells/mm³, or lymphocyte percentage < 25%. Subsequent blood sampling was conducted for those meeting these criteria. Results: Twenty-four children were included. The overall incidence of patients meeting both
criteria of inflammation and immunosuppression was 54%. Postoperative pPICS was significantly associated with a composite outcome of reoperation, hospital readmission, infection, ICU admission, or death. However, our data did not support any associations between preoperative cell phenotyping
or cytokine levels and the development of postoperative pPICS. Conclusion: We identified a high incidence of postoperative pPICS biomarkers in pediatric surgical patients, with significant associations to adverse clinical outcomes such as reoperation, readmission, infection, ICU admission, or death. Despite the presence of preoperative granulocytic MDSCs, no direct correlation with these outcomes was observed. The complex role of MDSCs and cytokine profiles in pPICS underscores the need for further research into its pathophysiology.
Downloads
References
1. Santarelli MD, Davis KA, Stark RJ. Persistent Inflammation, Immunosuppression, and Catabolism Syndrome in Pediatric Populations: A Brief Perspective. Curr Pediatr Rev [Internet]. 2024 May 14;20:7–10. Available from: https://www.eurekaselect.com/229941/article
2. Mira JC, Brakenridge SC, Moldawer LL, Moore FA. Persistent Inflammation, Immunosuppression and Catabolism Syndrome. Crit Care Clin [Internet]. 2017;33(2):245–58. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L614730178&from=export
3. Mira JC, Gentile LF, Mathias BJ, Efron PA, Brakenridge SC, Mohr AM, et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med [Internet]. 2017;45(2):253–62. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L612245136&from=export
4. Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol [Internet]. 2021 Aug 1;21(8):485–98. Available from: http://dx.doi.org/10.1038/s41577-020-00490-y
5. Bergenfelz C, Leandersson K. The Generation and Identity of Human Myeloid-Derived Suppressor Cells. Front Oncol. 2020;10(February):17–9.
6. Efron PA, Mohr AM, Bihorac A, Horiguchi H, Hollen MK, Segal MS, et al. Persistent inflammation, immunosuppression, and catabolism and the development of chronic critical illness after surgery. Surgery [Internet]. 2018 Aug;164(2):178–84. Available from: https://doi.org/10.1016/j.surg.2018.04.011
7. Elm E von, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ [Internet]. 2007 Oct 20;335(7624):806–8. Available from: https://www.bmj.com/lookup/doi/10.1136/bmj.39335.541782.AD
8. Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, et al. Persistent inflammation and immunosuppression. Journal of Trauma and Acute Care Surgery [Internet]. 2012 Jun;72(6):1491–501. Available from: https://journals.lww.com/01586154-201206000-00010
9. Chadda KR, Puthucheary Z. Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities. Br J Anaesth [Internet]. 2024 Mar;132(3):507–18. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2029605116&from=export
10. Hauschild DB, Oliveira LDA, Ventura JC, Farias MS, Barbosa E, Bresolin NL, et al. Persistent inflammation, immunosuppression and catabolism syndrome (PICS) in critically ill children is associated with clinical outcomes: a prospective longitudinal study. Journal of Human Nutrition and Dietetics [Internet]. 2021 Apr 7;34(2):365–73. Available from: https://onlinelibrary.wiley.com/doi/10.1111/jhn.12798
11. Patterson SG, Lamb CK, Gong W, Resser J, Lindsell CJ, Van Driest SL, et al. Pediatric Persistent Inflammation, Immunosuppression, and Catabolism Syndrome Prevalence in Sepsis-Related Mortalities. Chest [Internet]. 2023 Nov;164(5):1204–15. Available from: https://doi.org/10.1016/j.chest.2023.05.002
12. Adigbli D, Liu R, Meyer J, Cohen J, Di Tanna GL, Gianacas C, et al. Early persistent lymphopenia and risk of death in critically ill patients with and without sepsis. Shock [Internet]. 2024 Feb;61(2):197–203. Available from: https://journals.lww.com/shockjournal/fulltext/2024/02000/early_persistent_lymphopenia_and_risk_of_death_in.5.aspx
13. MEAKINS JL, PIETSCH JB, BUBENICK O, KELLY R, RODE H, GORDON J, et al. Delayed Hypersensitivity. Ann Surg [Internet]. 1977 Sep;186(3):241–50. Available from: http://journals.lww.com/00000658-197709000-00002
14. Felmet KA, Hall MW, Clark RSB, Jaffe R, Carcillo JA. Prolonged Lymphopenia, Lymphoid Depletion, and Hypoprolactinemia in Children with Nosocomial Sepsis and Multiple Organ Failure. The Journal of Immunology [Internet]. 2005 Mar 15;174(6):3765–72. Available from: https://journals.aai.org/jimmunol/article/174/6/3765/8435/Prolonged-Lymphopenia-Lymphoid-Depletion-and
15. Lindell RB, Zhang D, Bush J, Wallace DC, Rabinowitz JD, Lu W, et al. Impaired Lymphocyte Responses in Pediatric Sepsis Vary by Pathogen Type and are Associated with Features of Immunometabolic Dysregulation. Shock [Internet]. 2022 Jun;57(6):191–9. Available from: https://journals.lww.com/10.1097/SHK.0000000000001943
16. Podd BS, Banks RK, Reeder R, Telford R, Holubkov R, Carcillo J, et al. Early, Persistent Lymphopenia Is Associated With Prolonged Multiple Organ Failure and Mortality in Septic Children. Crit Care Med [Internet]. 2023 Dec 18;51(12):1766–76. Available from: https://journals.lww.com/10.1097/CCM.0000000000005993
17. Mira JC, Brakenridge SC, Moldawer LL, Moore FA. Persistent Inflammation, Immunosuppression and Catabolism Syndrome. Crit Care Clin [Internet]. 2017 Apr;33(2):245–58. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0749070416301130
18. Cassetta L, Baekkevold ES, Brandau S, Bujko A, Cassatella MA, Dorhoi A, et al. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates. Cancer Immunology, Immunotherapy [Internet]. 2019 Apr 25;68(4):687–97. Available from: http://dx.doi.org/10.1007/s00262-019-02302-2
19. Sharpe AH, Pauken KE. The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol [Internet]. 2018 Mar 13;18(3):153–67. Available from: https://www.nature.com/articles/nri.2017.108
20. Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res [Internet]. 2020;10(3):727–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32266087
21. Ellis N, Hughes C, Mazurak V, Joynt C, Larsen B. Does Persistent Inflammatory Catabolic Syndrome Exist in Critically Ill Neonates? Journal of Parenteral and Enteral Nutrition [Internet]. 2017 Nov 10;41(8):1393–8. Available from: https://aspenjournals.onlinelibrary.wiley.com/doi/10.1177/0148607116672621
Downloads
Published
Issue
Section
License
Copyright (c) 2026 João Vitor Casimiro Mendes de Oliveira, Vanessa Carregaro, Gabrielly Bindo Trindade, Michelle Alves de Mello, Juliana Cristina Costa-Madeira, Gustavo Santos Paiva Laender Moura, Persio Roxo-Junior, Fábio Antônio Perecim Volpe, Fabio Carmona

This work is licensed under a Creative Commons Attribution 4.0 International License.



